Epilepsy Foundation New Therapy Commercialization Grants Program

Epilepsy Foundation New Therapy Commercialization Grants Program Letter of Intent Due: February 16, 2015 by 11:59 PM Eastern Time If LOI is accepted, Proposal is Due: March 30, 2015 by 11:59 PM Eastern Time New Therapy Commercialization Grants Program The Epilepsy Foundation - New Therapy Commercialization Grants Program supports the development of more effective therapies by serving as a catalyst for moving innovative therapies from the laboratory to the patient. Investigators must hold a relevant advanced degree (M.D., and/or Ph.D.), and have completed all research training. This call for proposals is open to investigators at corporations as well as the academic/university arena. For the New Therapy–Commercialization Grants, the Epilepsy Foundation encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. These matching funds seek to leverage other resources, and accelerate the pace of therapeutic advances. Preference will be given to proposals that already have a commercial partner engaged to assist with development and to proposals that have committed or matched funding from the sponsoring institution, commercial partner or other third party source. For the New Therapy Commercialization Grants, applicants must demonstrate background work beyond the basic science discovery stage.
Source: ScanGrants feed - Category: Research Authors: Source Type: funding